Open-Label Exploratory, Multiple-Dose Study of Ceftobiprole to Evaluate the Pharmacokinetics and Broncho Alveolar Penetration in Adults With Ventilator-Associated Pneumonia.

Trial Profile

Open-Label Exploratory, Multiple-Dose Study of Ceftobiprole to Evaluate the Pharmacokinetics and Broncho Alveolar Penetration in Adults With Ventilator-Associated Pneumonia.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 27 Jul 2012

At a glance

  • Drugs Ceftobiprole medocaril (Primary)
  • Indications Nosocomial pneumonia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 27 Jul 2012 Company Johnson and Johnson Pharmaceutical added as association as reported by ClinicalTrials.gov record.
    • 27 Jul 2012 Actual initiation date changed from Sept 2008 to Oct 2008 as reported by ClinicalTrials.gov record.
    • 27 Jul 2012 Actual end date 1 Nov 2009 added as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top